Streetbeat News

Products Services

SOPA

Society Pass Incorporated (NASDAQ:SOPA) has officially launched its digital advertising platform, Thoughtful Media Group Inc (TMG), in the Philippines market. TMG has expanded its ecosystem of multi-platform advertising services through a network of more than 10,000 creators across multiple industries in Southeast Asia. The company is well positioned to benefit from the forecasted increase in digital advertising revenues in the Philippines over the next decade.

Portfolio Pulse from Happy Mohamed

October 17, 2023 | 12:15 pm

MSFT

NFLX

SONY

Netflix is expanding its gaming offerings to more devices, including TVs, computers, and mobiles. The company has launched a limited beta test in Canada and the U.K. on select TVs and on PCs and Macs through Netflix.com. The test includes two games: Oxenfree and Molehew's Mining Adventure. Netflix also plans to release games based on its hit franchises. The company's shares traded higher by 0.05% at $361.01 premarket on the last check Tuesday.

Portfolio Pulse from Anusuya Lahiri

October 17, 2023 | 12:15 pm

HLGN

WDS

Heliogen has announced advancements in its 5MWe commercial-scale renewable power project, in collaboration with Woodside Energy and the U.S. Department of Energy. The particle receiver prototype design verification is a significant milestone in the project.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:13 pm

NXTC

NextCure, Inc. (NASDAQ:NXTC) has presented new preclinical data showing that its novel anti-Siglec-15 antibody, NC605, reduced bone loss and improved bone quality in mice with osteogenesis imperfecta (OI). The results support the development of NC605 as a potential treatment for OI, a rare disease causing bones to fracture easily.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:09 pm

LDOS

Leidos Partnership for Defense Health (LPDH) has successfully deployed the MHS GENESIS electronic health record to an additional 9,000 Department of Defense (DOD) clinicians and providers as part of its first Outside of the Contiguous United States (OCONUS) deployment. The current system deployment spans 10 Military Treatment Facilities (MTFs) across Europe and the United Kingdom. LPDH also deployed MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba. The system is now operational at over 3,500 locations and reaches over seven million DOD beneficiaries.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:08 pm

SONN

Sonnet Biotherapeutics has announced that interim data from the SB101 trial of SON-1010 (Il12- FHAB) will be presented by Dr. Sant Chawla, a key opinion leader in the field of sarcoma research, at the upcoming Connective Tissue Oncology Society Annual.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:07 pm

LQR

LQR House Inc. (NASDAQ:LQR), a marketing agency in the spirits and beverage industry, has formed a strategic alliance with Beväge®, a consumer product from entrepreneur Dean Levin. LQR House will lead website development and marketing strategy for Beväge®, leveraging its connection with CWSpirits.com and a network of over 550 alcohol industry influencers. XMedia has been enlisted to develop the e-commerce platform and its associated SEO and paid strategies.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:06 pm

CRBP

Corbus Pharmaceuticals has announced the publication of data for its Cannabinoid Type-1 Receptor Inverse Agonist in a preclinical model of obesity. The company will also present this data at Obesity Week 2023.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:05 pm

DD

X

United States Steel Corporation (NYSE:X) and DuPont (NYSE:DD) have launched COASTALUME, a GALVALUME solution designed for coastal environments. The product combines U. S. Steel's GALVALUME solution with DuPont's Tedlar polyvinyl fluoride film barrier. The product is exclusively available through U. S. Steel.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:05 pm

OCEA

Ocean Biomedical has announced the enrollment of patients for a Phase 1b study for chronic Hepatitis B treatment. This is part of a 50-50 joint venture with Virion Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:04 pm